Expression pattern of a newly recognized protein, LECT2, in hepatocellular carcinoma and its premalignant lesion

Pathology International

Volumn 49, Issue 2, 1999, Pages 147-151

  Uchida, Toshikazu ^a   Nagai, Hisakazu ^a   Gotoh, Kenichiro ^b   Kanagawa, Hiroshi ^b   Kouyama, Harukazu ^b   Kawanishi, Teruaki ^b   Mima, Satoaki ^b   Yamagoe, Satoshii ^c   Suzuki, Kazuo ^c  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ianzumi Park Hospital   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Atypical hyperplasia; Borderline lesion; Cell cycle; Hepatocellular carcinoma; LECT2

Indexed keywords

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOPEROXIDASE STAINING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; NEUTROPHIL; ONCOGENE MYC; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; TUMOR VASCULARIZATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOTACTIC FACTORS; CHILD, PRESCHOOL; CYTOPLASM; FEMALE; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROTEINS;

EID: 0033002008     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00836.x     Document Type: Article

References (15)

1. 1 Yamagoe S, Yamakawa Y, Matsuo Y, Minowada J, Mizuno S, Suzuki K. Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2. Immunol. Lett. 1996; 52:9-13.
2. 2 Yamagoe S, Mizuno S, Suzuki K. Molecular cloning of human and bovine LECT2s having a neutrophil chemotactic activity and its specific expression in the liver. Biochem. Biophys. Acta 1998; 1396: 105-113.
3. 3 Ness SA, Marknell A, Graf T. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 1989; 59: 1115-1125.
4. 4 Yamagoe S, Akasaka T, Uchida T et al. Expression of a neutrophil chemotactic protein LECT2 in human hepatocytes revealed by immunochemical studies using polyclonal and monoclonal antibodies to a recombinant LECT2. Biochem. Biophys. Res. Commun. 1997; 237: 116-120.
5. 5 Nagai H, Hamada T, Uchida T, Yamagoe S, Suzuki K. Systemic expression of a newly recognized protein, LECT2, in the human body. Pathol Int. 1998; 48: 882-886.
6. 6 Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-675.
7. 7 Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986; 6: 729-738.
8. 8 Uchida T. Small hepatocellular carcinoma: Its relationship to multistep hepatocarcinogenesis. Pathol. Int. 1995; 45: 175-184.
9. 9 Nakano M, Saito A, Yamamoto M, Doi M, Takasaki K. Stromal and blood vessel wall invasion in well-differentiated hepatocellular carcinoma. Liver 1997; 17: 41-46.
10. 10 Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
11. 11 Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
12. 12 Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427-428.
13. 13 Jajicek G, Oren R, Weinreb M. The streaming liver. Liver 1985; 5: 293-300.
14. 14 Fausto N, Mead J. Regulation of liver growth: Protooncogenes and transforming growth factors. Lab. Invest. 1989; 60: 4-13.
15. 15 Hiraki Y, Inoue H, Kondo J et al. A novel growth-promoting factor derived from fetal bovine cartilage, chondromodulin II. J. Biol. Chem. 1996; 271: 22 657-22 662.